J. Safra Sarasin Holding AG Buys New Position in Corteva, Inc. $CTVA

J. Safra Sarasin Holding AG purchased a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 10,215 shares of the company’s stock, valued at approximately $855,000.

A number of other large investors also recently modified their holdings of CTVA. Drummond Knight Asset Management Pty Ltd purchased a new position in shares of Corteva during the 4th quarter valued at approximately $25,713,000. Avior Wealth Management LLC raised its stake in shares of Corteva by 464.7% during the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after purchasing an additional 27,075 shares in the last quarter. Arbejdsmarkedets Tillaegspension bought a new stake in shares of Corteva in the 4th quarter valued at approximately $23,679,000. Mirae Asset Global Investments Co. Ltd. raised its position in Corteva by 23.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after acquiring an additional 20,957 shares in the last quarter. Finally, Leonteq Securities AG acquired a new position in shares of Corteva during the 4th quarter worth $2,350,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Trading Down 1.3%

Corteva stock opened at $84.91 on Wednesday. The business has a 50-day simple moving average of $80.53 and a two-hundred day simple moving average of $77.87. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $87.69. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a market cap of $56.79 billion, a P/E ratio of 49.95, a P/E/G ratio of 2.63 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Oppenheimer raised their target price on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Barclays increased their target price on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Berenberg Bank boosted their price objective on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Finally, Morgan Stanley upped their target price on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $88.95.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.